# Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

> **NCT05450367** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 249 (actual)

## Conditions studied

- Blood Cancer

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT05450367
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450367, "Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05450367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*